Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.
Here's what stood out today:
📌 Perimeter Solutions $PRM – Windacre Partnership filed a Form 4 for $3.56 million.
They’re known for concentrated bets, and this is a solid size for a specialty chemicals stock completing a multi-year base.
When Windacre shows up, it’s rarely passive.
📌 Gamestop $GME – Director James Grube filed a Form 4 for $132,000.
Not giant, but Gamestop is never boring.
Insider buying at these levels is notable, especially as the meme-fueled volatility calms down.
Here’s The Hot Corner, with data from July 1, 2025:
You have probably heard me talk about the Three B’s before.
It stands for banks, biotechs, and builders, and is a fun and convenient acronym I use when discussing the most interest rate-sensitive stocks.
These groups could not be more different, but they share a key similarity in the sense that they all move in synchrony with the bond market.
Biotechs are some of the longest-duration equities, so lower rates boost their valuations. It also allows these chronic cash-burners to access capital cheaply.
Builders sell houses, and lower rates are the key demand driver, so that one is obvious.
And banks are new to the lower rates list.
We used to say banks want higher rates, or a higher spread—it’s how they make money. However, that changed recently as asset-liability matching issues arose from lending operations during the last rate-...
There weren’t any S&P 500 earnings reactions yesterday…
But we did get fresh monthly and quarterly closing data, and one industry group is demanding our attention.
Cybersecurity.
This has become one of the most powerful secular themes in tech, and it’s only gaining momentum.
As digital threats become increasingly sophisticated, companies and governments are being compelled to invest heavily in protecting their data, systems, and users.
From ransomware payouts to state-sponsored espionage, the battlefield is expanding, and the stakes have never been higher.
In today’s cloud-first world, there’s more surface area to defend than ever before.
This isn’t a cyclical trade.
It’s structural...
It’s global...
And it’s urgent!
The result? Cybersecurity is now one of the fastest-growing categories in enterprise IT.
Budgets are rising, and the revenue is sticky.
The opportunity set for leading cyber firms is expanding rapidly.
This is where real money will be made over the next decade.
Let’s break down the charts and highlight one stock that’s already starting to separate from the...
Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.
Here's what stood out today:
📌 Cidara Therapeutics $CDTX – RA Capital Healthcare Fund filed a Form 4 for $100 million.
That’s not a trade – it’s a statement.
RA is one of biotech’s sharpest players, and this kind of size is the ultimate tell, especially after the stock has doubled in 2025.
📌 Kymera Therapeutics $KYMR – Julian Baker just filed a $28.84 million Form 4.
When Baker Bros start writing checks this big, it usually isn’t for fun.
A monster-sized vote of confidence in the biotech space for a stock completing a multi-year base deserves attention.
I had a thought this morning while considering a few trades:
Maybe part of why I still struggle at trading sometimes is because there’s a part of me that really, really wants to follow an instruction manual to be successful.
In other areas of my life, that mindset serves me well.
I don’t know how to cook—but give me step-by-step directions, and I thrive. When we used to get HelloFresh boxes delivered, I crushed those meals. I followed the instructions, made something delicious and useful for my family, and felt like a total champ.
Following the instructions = success. I like that. I crave that.
But trading isn’t like that.
I can lay out a well-thought-out plan—how to select the trade, how to size it, how to manage it—and still lose money.
The market doesn’t care that I followed the recipe.
There’s no gold star just for executing cleanly.
And yeah, I know a successful outcome in trading is supposed to mean I followed my plan with discipline. I know.
But that doesn’t make a loss feel any better. Which leads to the uncomfortable question I’ve been sitting with:
We've had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.
For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.
That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.
We expanded our universe to include some mid-caps.
Nowadays, to make the cut for our Minor Leaguers list, a company must have a market cap between $1 and $4B.
And it doesn't have to be a Russell component — it can be any US-listed equity. With participation expanding around the globe, we want all those ADRs in our universe.
The same price and liquidity filters are applied. Then, as always, we sort by proximity to new...